Austedo
Deutetrabenazine
- Strength
- 12 mg/1
- Form
- Tablet, Coated
Teva Neuroscience, Inc.
Not stocked by us — reference only
deutetrabenazine
Listed by Teva Neuroscience, Inc.
| Dosage form | Tablet, Film Coated, Extended Release |
|---|---|
| Route | Oral |
| Approval route | NDA — original brand approval |
| NDC code | 68546-473 |
| FDA application | NDA216354 |
| RxNorm concept | 1876910 |
| Package sizes listed | 1 |
| Marketed since | May 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Deutetrabenazine
Teva Neuroscience, Inc.
Not stocked by us — reference only
Deutetrabenazine
Teva Neuroscience, Inc.
Not stocked by us — reference only
Deutetrabenazine
Teva Neuroscience, Inc.
Not stocked by us — reference only
deutetrabenazine
Teva Neuroscience, Inc.
Not stocked by us — reference only
deutetrabenazine
Teva Neuroscience, Inc.
Not stocked by us — reference only
deutetrabenazine
Teva Neuroscience, Inc.
Not stocked by us — reference only
deutetrabenazine
Teva Neuroscience, Inc.
Not stocked by us — reference only
deutetrabenazine
Teva Neuroscience, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.